Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).

We here report the design and synthesis of selective human lysosomal sialidase (NEU1) inhibitors. A series of amide-linked C9 modified DANA (2-deoxy-2,3-dehydro-N-acetylneuraminic acid) analogues were synthesized and their inhibitory activities against all four human sialidases (NEU1-NEU4) were determined. Structure-based approach was used to investigate the basis of selectivity of the compounds with experimentally observed activity. Results from the present study are found to be informative in a qualitative manner for the further design of isoform selective human sialidase inhibitors for therapeutic value.

[1]  K. Yamaguchi,et al.  Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Yamaguchi,et al.  Down‐regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers , 2007, Cancer science.

[3]  G. Borsani,et al.  Recent Development in Mammalian Sialidase Molecular Biology , 2002, Neurochemical Research.

[4]  T. Irimura,et al.  Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification. , 2006, Oncology research.

[5]  K. Yamaguchi,et al.  Evidence for mitochondrial localization of a novel human sialidase (NEU4). , 2005, The Biochemical journal.

[6]  E. Monti,et al.  Expression of Sialidase Neu2 in Leukemic K562 Cells Induces Apoptosis by Impairing Bcr-Abl/Src Kinases Signaling* , 2007, Journal of Biological Chemistry.

[7]  K. Yamaguchi,et al.  Plasma Membrane-associated Sialidase Is Up-regulated in Renal Cell Carcinoma and Promotes Interleukin-6-induced Apoptosis Suppression and Cell Motility* , 2006, Journal of Biological Chemistry.

[8]  Komandoor E. Achyuthan,et al.  Comparative enzymology, biochemistry and pathophysiology of human exo-α-sialidases (neuraminidases) , 2001 .

[9]  Taeko Miyagi,et al.  Aberrant Expression of Sialidase in Cancer , 2004 .

[10]  C. Venkatachalam,et al.  LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. , 2003, Journal of molecular graphics & modelling.

[11]  K. Koseki,et al.  A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells , 2007, Oncogene.

[12]  Soichi Wakatsuki,et al.  Crystal Structure of the Human Cytosolic Sialidase Neu2 , 2005, Journal of Biological Chemistry.

[13]  P. Alzari,et al.  Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase. , 2007, Bioorganic & medicinal chemistry.

[14]  Keiko Hata,et al.  Sialidase and malignancy: A minireview , 2003, Glycoconjugate Journal.

[15]  Tohru Suzuki,et al.  Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors. , 2006, Journal of molecular graphics & modelling.

[16]  M. Obinata,et al.  Overexpression of Plasma Membrane-associated Sialidase Attenuates Insulin Signaling in Transgenic Mice* , 2003, Journal of Biological Chemistry.

[17]  C. Schengrund,et al.  Biological Roles of Sialic Acid , 1976, Springer US.

[18]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[19]  J. C. Dyason,et al.  Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase. , 2006, Bioorganic & medicinal chemistry.